Serum Institute of India

Latest Headlines

Latest Headlines

Serum Institute of India poses challenge to Merck HPV vaccine

The Serum Institute of India, the world's fifth largest vaccinemaker by volume, is eyeing newer vaccines, including one for the human papillomavirus expected to be launched by late 2018 and sell at a third of the price of Merck & Co.'s blockbuster Gardasil, Bloomberg reported.

Powdered measles vaccine, safe in PhI, could aid vaccination in developing world

A powdered measles vaccine could mean a cheaper option for the developing world that eliminates storage, contamination and waste challenges. And researchers now have one that looks safe in Phase I.

India's Cipla breaks into vaccines with Serum deal in Europe

Indian generics maker Cipla is taking its low-cost game into the vaccine field, thanks to a new deal with the Serum Institute of India.

Serum targets Merck, Sanofi stronghold with TB vax deal

Serum Institute of India has a history of winning shares in established vaccine markets by undercutting the competition. And now it has bought the rights to a tuberculosis vaccine it believes can beat shots by Merck and Sanofi on effectiveness, as well as cost.

GSK, Biological E partner on childhood vaccine

Small Indian vaccine makers are starting to drum up low-cost shots for developing countries and Big Pharma wants to compete with these up-and-coming rivals. GlaxoSmithKline ($GSK) announced an agreement to team up with an Indian venture to produce a 6-in-1 vaccine to protect against polio and 5 other diseases.

India's vaccine prices soar as private companies gain ground

India, a country forging its way into the vaccine production business, has found itself descending into the clutches of its private sector.

Serum Institute will donate measles rubella vaccine to GAVI

The Serum Institute of India will donate 20 million doses of measles-rubella vaccine to the GAVI Alliance as part of that organization's initiative to reduce the mortality rate caused by measles-rubella in the developing world.

Merck, Serum Institute sign pneumococcal vaccine deal

Merck ($MRK) and the Serum Institute of India are joining forces to bring a pneumococcal conjugate vaccine to emerging and developing markets. The deal includes a product advisory committee that will

Vaccine makers cut prices for developing countries

Just over a week after UNICEF began publishing vaccine prices, many vaccine producers including GlaxoSmithKline and Merck have announced they will cut their vaccine prices for developing countries.

Gates funds two Indian vaccine firms

The Bill and Melinda Gates philanthropy machine rolls on. This week the foundation is backing two firms in India researching vaccines for pneumonia and diarrhea. Both Bharat Biotech and Serum